Quebec is the first province to publicly cover costs of long-acting injectable HIV prevention medication Apretude. Experts say it's a much-needed, long-awaited tool — and they're pushing to make it ...

A research group led by Professor Wei Li from the Department of Pharmacognosy, Faculty of Pharmaceutical Sciences, Toho ...

The U.S. Health and Human Services Department is weighing plans to drastically cut federal government funding for domestic ...

Over the last 25 years, (ED) medications such as Viagra and others have become common and normal pieces of bedroom tool kit.

The first round of $175,000 in Big Pharma funds goes to local agencies devoted to education, prevention, intervention, harm ...

The project has four roving clinics that influencers are contracted to visit to brand HIV prevention as hip and ‘cool’ ...

A clinical trial suggests Lenacapavir, a yearly injection, could revolutionise HIV prevention by offering long-term ...

Gilead is set to launch a Phase III trial of its once-yearly lenacapavir pre-exposure prophylaxis (PrEP) for human ...

HIV infections (human immunodeficiency virus infections) include the spectrum of infections caused by the virus HIV that range from asymptomatic seropositivity to acquired immunodeficiency ...

I’ve spent a lot of time around pocket knives over the years, testing blades from many brands you’ve probably heard of—and a few you might not. And while I’ve only scratched the surface of ...

Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study by researchers at UCSF has found. The strategy could also help stop the spread of HIV by ...